NASDAQ:RARE | EBITDA | Ultragenyx Pharmaceutical Inc.

Complete source-backed ebitda history.

Available history
2012-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$161M
2025-12-31-$104.5M
2025-03-31-$134M
2024-12-31-$112.77M
2024-03-31-$156.5M
2023-12-31-$113.63M
2023-03-31-$148.87M
2022-12-31-$140.67M
2022-03-31-$132.54M
2021-12-31-$99.03M
2021-03-31-$103.2M
2020-12-31-$92.95M
2020-03-31-$117.81M
2019-12-31-$92.28M
2019-03-31-$97.1M
2018-12-31-$87.4M
2018-03-31-$90.33M
2017-12-31-$94.32M
2017-03-31-$68.79M
2016-12-31-$69.39M
2016-03-31-$53.08M
2015-12-31-$55.68M
2015-03-31-$21.3M
2014-12-31-$16.73M
2014-03-31-$10.22M
2013-12-31-$9.41M
2013-03-31-$6.62M

Annual EBITDA

DateEBITDA
2025-12-31-$500M
2024-12-31-$500M
2023-12-31-$543M
2022-12-31-$630.7M
2021-12-31-$368.5M
2020-12-31-$317.86M
2019-12-31-$415.63M
2018-12-31-$351.84M
2017-12-31-$323.12M
2016-12-31-$244.58M
2015-12-31-$146.35M
2014-12-31-$56.09M
2013-12-31-$31.84M
2012-12-31-$15.67M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.